|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities of continuing operations: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Loss (income) from discontinued operations | |||||
| Depreciation expense | |||||
| Intangible asset amortization expense | |||||
| Deferred financing costs and debt discount amortization expense | |||||
| Loss on extinguishment of debt | |||||
| Gain on non-designated foreign currency forward contracts | |||||
| Pension settlement charge | |||||
| Fair value step up of acquired inventory sold | |||||
| Changes in contingent consideration | |||||
| Asset impairments | |||||
| Stock-based compensation | |||||
| Gain on sale of assets and business | |||||
| Goodwill impairment charge | |||||
| Deferred income taxes, net | |||||
| Payments for contingent consideration | |||||
| Interest benefit on swaps designated as net investment hedges | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions and disposals: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Income taxes | |||||
| Net cash provided by operating activities from continuing operations | |||||
| Cash flows from investing activities of continuing operations: | |||||
| Expenditures for property, plant and equipment | |||||
| Payments for businesses and intangibles acquired, net of cash acquired | |||||
| Proceeds on non-designated balance sheet hedges | |||||
| Proceeds from sales of business and assets | |||||
| Insurance settlement proceeds | |||||
| Net interest proceeds on swaps designated as net investment hedges | |||||
| Proceeds from sales of investments | |||||
| Purchase of investments | |||||
| Net cash (used in) provided by investing activities from continuing operations | |||||
| Cash flows from financing activities of continuing operations: | |||||
| Proceeds from new borrowings | |||||
| Reduction in borrowings | |||||
| Debt extinguishment, issuance and amendment fees | |||||
| Repurchase of common stock | |||||
| Net proceeds from share based compensation plans and the related tax impacts | |||||
| Payments for contingent consideration | |||||
| Dividends paid | |||||
| Proceeds from sale of treasury stock | |||||
| Excise tax paid on repurchase of common stock | |||||
| Net cash provided by (used in) financing activities from continuing operations | |||||
| Cash flows from discontinued operations: | |||||
| Net cash provided by operating activities | |||||
| Net cash used in investing activities | |||||
| Net cash provided by (used in) discontinued operations | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash equivalents | |||||
| Cash, cash equivalents and restricted cash equivalents at the beginning of the year | |||||
| Less: Cash, cash equivalents and restricted cash of discontinued operations | |||||
| Cash, cash equivalents and restricted cash equivalents at the end of the year | |||||
Loading...